ATE361376T1 - Membranfraktionen von mit 1,2-sn-diacylglycerol angereicherten zellen - Google Patents

Membranfraktionen von mit 1,2-sn-diacylglycerol angereicherten zellen

Info

Publication number
ATE361376T1
ATE361376T1 AT01982564T AT01982564T ATE361376T1 AT E361376 T1 ATE361376 T1 AT E361376T1 AT 01982564 T AT01982564 T AT 01982564T AT 01982564 T AT01982564 T AT 01982564T AT E361376 T1 ATE361376 T1 AT E361376T1
Authority
AT
Austria
Prior art keywords
diacylglycerol
membrane fractions
cells enriched
mgdg synthase
enriched
Prior art date
Application number
AT01982564T
Other languages
English (en)
Inventor
Eric Marechal
Stephane Miras
Jacques Joyard
Original Assignee
Commissariat Energie Atomique
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat Energie Atomique, Centre Nat Rech Scient filed Critical Commissariat Energie Atomique
Application granted granted Critical
Publication of ATE361376T1 publication Critical patent/ATE361376T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/16—Enzymes or microbial cells immobilised on or in a biological cell
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT01982564T 2000-10-31 2001-10-26 Membranfraktionen von mit 1,2-sn-diacylglycerol angereicherten zellen ATE361376T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0013976A FR2815968B1 (fr) 2000-10-31 2000-10-31 Fractions membranaires de cellules enrichies en 1,2-sn- diacylglycerol, procede de preparation et utilisations

Publications (1)

Publication Number Publication Date
ATE361376T1 true ATE361376T1 (de) 2007-05-15

Family

ID=8855938

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01982564T ATE361376T1 (de) 2000-10-31 2001-10-26 Membranfraktionen von mit 1,2-sn-diacylglycerol angereicherten zellen

Country Status (9)

Country Link
US (1) US7435583B2 (de)
EP (1) EP1330537B1 (de)
JP (1) JP4024147B2 (de)
AT (1) ATE361376T1 (de)
AU (2) AU1411302A (de)
CA (1) CA2427267A1 (de)
DE (1) DE60128252T2 (de)
FR (1) FR2815968B1 (de)
WO (1) WO2002036811A1 (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2790915B1 (fr) * 1999-03-19 2001-06-01 Commissariat Energie Atomique Procede de criblage et de selection d'antiparasitaires apicomplexes et/ou d'herbicides et ses applications

Also Published As

Publication number Publication date
FR2815968B1 (fr) 2005-01-07
US7435583B2 (en) 2008-10-14
WO2002036811A1 (fr) 2002-05-10
CA2427267A1 (fr) 2002-05-10
AU1411302A (en) 2002-05-15
JP2004529612A (ja) 2004-09-30
DE60128252T2 (de) 2008-01-10
EP1330537B1 (de) 2007-05-02
JP4024147B2 (ja) 2007-12-19
EP1330537A1 (de) 2003-07-30
US20040013739A1 (en) 2004-01-22
AU2002214113B2 (en) 2006-02-23
FR2815968A1 (fr) 2002-05-03
DE60128252D1 (de) 2007-06-14

Similar Documents

Publication Publication Date Title
CY1112101T1 (el) Νευροτροφικοι παραγοντες
EP1176983A4 (de) HYPERVERZWEIGTE, POLYMERE MIZELLEN ZUR EINKAPSELUNG UND ZUFüHRUNG VON HYDROPHOBEN MOLEKüLEN
TR199902426T2 (xx) Bitki b�ceklerinin kontrol�.
DE69838147D1 (de) Verbindungen und methoden zur modulierung von occludin-abhängiger gewebepermeabilität
DE69942459D1 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
ATE408422T1 (de) Methode zur hemmung immunstimulatorischer mit dna assoziierter antworten
EP1131333A4 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
EP1687283A4 (de) Für die bestimmung von fk506 geeignetes verfahren und zusammensetzung
ATE476495T1 (de) Bazillus thuringiensis und dessen insektizide proteine
BR0207775A (pt) Lipossomos anfotéricos métodos para carregamento dos mesmos com ingredientes ativos e sua utilização
FI962247L (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät
ATE415480T1 (de) B7l-1 moleküle
SE9802729D0 (sv) Novel Compounds
DE69534551D1 (de) Neue methode zum auffindenund bewerten biologisch aktiver moleküle
ATE439441T1 (de) Veränderte, fluoreszierende proteine
ATE473273T1 (de) Angereicherte zellpopulationen des zentralen nervensystems
DK1082423T3 (da) Cyclin E2-gener og -proteiner
IS7154A (is) Bv8 kjarnsýrur og fjölpeptíð með mítósu-valdandi verkun
DE60027735D1 (de) Genetische screeningverfahren
ATE291586T1 (de) Humanes antibiotisches protein
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
BR0008187A (pt) Controle biológico de nematódeos
ATE361376T1 (de) Membranfraktionen von mit 1,2-sn-diacylglycerol angereicherten zellen
EP1358207A4 (de) Sol-fusin: verwendung von gp64-6his zur katalysierung der membranfusion
DE69838615D1 (de) ppGpp-SYNTHETASE UND EXPRESSIONSSYSTEME ZUR VERBESSERTEN HERSTELLUNG VON PROTEINEN

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties